As the US government gets back to normal operations after the shutdown, Sally Rockey, the deputy director for extramural research at the National Institutes of Health, writes at her blog there will be some rescheduling of grant submissions.
Registering provides access to this and other free content.
Already have an account?Login Now.
The New York Times' George Johnson muses on cancer's roots in multicellularity.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.